ADMA BIOLOGICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
ADMA BIOLOGICS, INC. (ADMA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of -11.60 thousand shares for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-05.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2020-11-05
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-09-30 was -4.83K shares, a 167.51% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-06-30 was -11.62K shares, a 657.61% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-03-31 was 4.85K shares, a 29.73% increase year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-12-31 was 7.00K shares, a 68.25% decline year-over-year.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 19.98K shares, a 42.06% decline from fiscal 2018.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 34.49K shares, a 27.35% decline from fiscal 2017.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 47.48K shares, a 447.84% increase from fiscal 2016.
- ADMA BIOLOGICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 8.67K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | -4.83K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -16.45K shares derived: sum of 2 quarters · filed 2020-11-05 | -11.60K shares 10-Q · filed 2020-11-05 | -4.60K shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | -11.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -6.76K shares 10-Q · filed 2020-08-05 | 235.00 shares derived: sum of 3 quarters · filed 2020-08-05 | 7.40K shares derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | 4.85K shares 10-Q · filed 2020-05-06 | 11.85K shares derived: sum of 2 quarters · filed 2020-05-06 | 19.01K shares derived: sum of 3 quarters · filed 2020-05-06 | 21.09K shares derived: sum of 4 quarters · filed 2020-05-06 |
| 2019-12-31 | 7.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 14.16K shares derived: sum of 2 quarters · filed 2020-03-13 | 16.24K shares derived: sum of 3 quarters · filed 2020-03-13 | 19.98K shares 10-K · filed 2020-03-13 |
| 2019-09-30 | 7.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | 9.24K shares derived: sum of 2 quarters · filed 2019-11-06 | 12.98K shares 10-Q · filed 2019-11-06 | 35.03K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-06-30 | 2.08K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | 5.82K shares 10-Q · filed 2019-08-08 | 27.87K shares derived: sum of 3 quarters · filed 2020-03-13 | 37.98K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2019-03-31 | 3.74K shares 10-Q · filed 2019-05-08 | 25.78K shares derived: sum of 2 quarters · filed 2020-03-13 | 35.90K shares derived: sum of 3 quarters · filed 2020-03-13 | 35.90K shares derived: sum of 4 quarters · filed 2020-03-13 |
| 2018-12-31 | 22.04K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | 32.16K shares derived: sum of 2 quarters · filed 2020-03-13 | 32.16K shares derived: sum of 3 quarters · filed 2020-03-13 | 34.49K shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 10.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 10.11K shares derived: sum of 2 quarters · filed 2018-11-09 | 12.45K shares 10-Q · filed 2018-11-09 | 46.20K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | 2.33K shares 10-Q · filed 2018-08-10 | 36.08K shares derived: sum of 3 quarters · filed 2019-03-13 | 42.12K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2018-03-31 | 2.33K shares 10-Q · filed 2018-05-14 | 36.08K shares derived: sum of 2 quarters · filed 2019-03-13 | 42.12K shares derived: sum of 3 quarters · filed 2019-03-13 | 43.56K shares derived: sum of 4 quarters · filed 2019-03-13 |
| 2017-12-31 | 33.75K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 39.79K shares derived: sum of 2 quarters · filed 2019-03-13 | 41.23K shares derived: sum of 3 quarters · filed 2019-03-13 | 47.48K shares 10-K · filed 2019-03-13 |
| 2017-09-30 | 6.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | 7.48K shares derived: sum of 2 quarters · filed 2017-11-03 | 13.73K shares 10-Q · filed 2017-11-03 | 13.73K shares derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-06-30 | 1.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | 7.69K shares 10-Q · filed 2017-08-11 | 7.69K shares derived: sum of 3 quarters · filed 2018-03-29 | |
| 2017-03-31 | 6.25K shares 10-Q · filed 2017-05-12 | 6.25K shares derived: sum of 2 quarters · filed 2018-03-29 | ||
| 2016-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | 8.67K shares 10-K · filed 2018-03-29 | ||
| 2016-09-30 | 8.67K shares 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |